SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001854270-24-000087
Filing Date
2024-07-12
Accepted
2024-07-12 16:17:24
Documents
1
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1720815436.html 4  
1 FORM 4 wk-form4_1720815436.xml 4 4034
  Complete submission text file 0001854270-24-000087.txt   5736
Mailing Address C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065
Business Address
Farokhzad Omid (Reporting) CIK: 0001586852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 241114684

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)